William P. Forbes, EVP Research&Devel & CDO at SALIX PHARMACEUTICALS LTD (SLXP), sold 8,000 shares at $90.06 ($720K) on 2014-01-08, disclosed to the SEC on 2014-01-10.
Scheduled sale ($720k) by EVP Research&Devel & CDO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| XAIR | BUY | 2023-04-03 | $33K | — | Filing → |
| XAIR | BUY | 2023-03-20 | $32K | — | Filing → |
| XAIR | BUY | 2019-11-15 | $25K | — | Filing → |